laboratory platform that combines automation and software for the planning, execution, and analysis of cell culture studies
mo:re has raised €2.3M across 1 funding round from 7 investors, most recently a round in Mar 2025. Based in Hamburg, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-26 | Other | €2.3M |
| Gilson,High-Tech Gründerfonds (HTGF),Innovationsstarter Fonds Hamburg (IFH),Martin Blüggel,Nedgex,Nidobirds Ventures+1 more |
| View deal → |
